{"id":"https://openalex.org/W7204154339","doi":"https://doi.org/10.1007/s10552-026-02236-y","title":"Racial and ethnic disparities in enrollment for clinical trials of poly (ADP-ribose) polymerase (PARP) inhibitors in breast cancer treatment","display_name":"Racial and ethnic disparities in enrollment for clinical trials of poly (ADP-ribose) polymerase (PARP) inhibitors in breast cancer treatment","alternate_titles":[],"publication_year":2026,"publication_date":"2026-08-25","ids":{"openalex":"https://openalex.org/W7204154339","doi":"https://doi.org/10.1007/s10552-026-02236-y","pmid":"https://pubmed.ncbi.nlm.nih.gov/42640385"},"language":"en","primary_location":{"id":"doi:10.1007/s10552-026-02236-y","doi":"https://doi.org/10.1007/s10552-026-02236-y","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s10552-026-02236-y","pdf_url":null,"source":{"id":"https://openalex.org/S150168663","display_name":"Cancer Causes & Control","issn_l":"0957-5243","issn":["0957-5243","1573-7225"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Causes &amp; Control","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W7204154339"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034568527","display_name":"Parnian Kheirkhah Rahimabad","orcid":"https://orcid.org/0000-0003-1751-1897","observed_orcids":["https://orcid.org/0000-0003-1751-1897"]},"institutions":[{"id":"https://openalex.org/I160606119","display_name":"University of Tennessee Health Science Center","ror":"https://ror.org/0011qv509","country_code":"US","type":"education","lineage":["https://openalex.org/I160606119"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Parnian Kheirkhah Rahimabad","raw_affiliation_strings":["Department of Radiation Oncology, University of Tennessee Health Science Center, Memphis, TN, USA. pkheirk1@uthsc.edu"],"raw_orcid":"https://orcid.org/0000-0003-1751-1897","affiliations":[{"raw_affiliation_string":"Department of Radiation Oncology, University of Tennessee Health Science Center, Memphis, TN, USA. pkheirk1@uthsc.edu","institution_ids":["https://openalex.org/I160606119"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032549218","display_name":"Simran Sekhon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I160606119","display_name":"University of Tennessee Health Science Center","ror":"https://ror.org/0011qv509","country_code":"US","type":"education","lineage":["https://openalex.org/I160606119"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Simran Sekhon","raw_affiliation_strings":["Division of Hematology and Oncology, Department of Internal Medicine, University of Tennessee Health Science Center, Memphis, TN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology, Department of Internal Medicine, University of Tennessee Health Science Center, Memphis, TN, USA","institution_ids":["https://openalex.org/I160606119"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112837575","display_name":"Elizabeth John","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I160606119","display_name":"University of Tennessee Health Science Center","ror":"https://ror.org/0011qv509","country_code":"US","type":"education","lineage":["https://openalex.org/I160606119"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth John","raw_affiliation_strings":["Division of Hematology and Oncology, Department of Internal Medicine, University of Tennessee Health Science Center, Memphis, TN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology, Department of Internal Medicine, University of Tennessee Health Science Center, Memphis, TN, USA","institution_ids":["https://openalex.org/I160606119"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5034568527"],"corresponding_institution_ids":["https://openalex.org/I160606119"],"apc_list":{"value":3890,"currency":"USD","value_usd":3890},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"37","issue":"9","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.9477999806404114,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.9477999806404114,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10582","display_name":"Ethics in Clinical Research","score":0.02969999983906746,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.010200000368058681,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.8659999966621399},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.8100000023841858},{"id":"https://openalex.org/keywords/racial-disparities","display_name":"racial disparities","score":0.7680000066757202},{"id":"https://openalex.org/keywords/ethnic-disparities","display_name":"ethnic disparities","score":0.9160000085830688},{"id":"https://openalex.org/keywords/clinical-trial-enrollment","display_name":"clinical trial recruitment","score":0.9380000233650208},{"id":"https://openalex.org/keywords/brca-mutations","display_name":"BRCA mutations","score":0.7680000066757202},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.9980000257492065},{"id":"https://openalex.org/keywords/black-patients","display_name":"Black patients","score":0.722000002861023},{"id":"https://openalex.org/keywords/hispanic-patients","display_name":"Hispanic patients","score":1.0},{"id":"https://openalex.org/keywords/asian-patients","display_name":"Asian patients","score":0.6600000262260437},{"id":"https://openalex.org/keywords/underrepresentation-in-clinical-trials","display_name":"underrepresentation in clinical trials","score":0.6420000195503235},{"id":"https://openalex.org/keywords/health-equity","display_name":"health equity","score":0.8420000076293945}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8916000127792358},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.7202000021934509},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7008000016212463},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.6557000279426575},{"id":"https://openalex.org/C156957248","wikidata":"https://www.wikidata.org/wiki/Q1862216","display_name":"Odds ratio","level":2,"score":0.5220999717712402},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5044999718666077},{"id":"https://openalex.org/C2779138821","wikidata":"https://www.wikidata.org/wiki/Q7118227","display_name":"PARP inhibitor","level":5,"score":0.49140000343322754},{"id":"https://openalex.org/C107130276","wikidata":"https://www.wikidata.org/wiki/Q133805","display_name":"Epidemiology","level":2,"score":0.4375},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.38019999861717224},{"id":"https://openalex.org/C27158222","wikidata":"https://www.wikidata.org/wiki/Q5532422","display_name":"Generalizability theory","level":2,"score":0.37369999289512634},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.3246000111103058},{"id":"https://openalex.org/C151956035","wikidata":"https://www.wikidata.org/wiki/Q1132755","display_name":"Logistic regression","level":2,"score":0.3239000141620636},{"id":"https://openalex.org/C137403100","wikidata":"https://www.wikidata.org/wiki/Q41710","display_name":"Ethnic group","level":2,"score":0.3043999969959259},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.26010000705718994}],"mesh":[{"descriptor_ui":"D000067856","descriptor_name":"Poly(ADP-ribose) Polymerase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000095223","descriptor_name":"White","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001213","descriptor_name":"Asian","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001741","descriptor_name":"Black or African American","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000208","qualifier_name":"ethnology","is_major_topic":true},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005006","descriptor_name":"Ethnicity","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006630","descriptor_name":"Hispanic or Latino","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018579","descriptor_name":"Patient Selection","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D044469","descriptor_name":"Racial Groups","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D054625","descriptor_name":"Healthcare Disparities","qualifier_ui":"Q000208","qualifier_name":"ethnology","is_major_topic":true},{"descriptor_ui":"D054625","descriptor_name":"Healthcare Disparities","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1007/s10552-026-02236-y","doi":"https://doi.org/10.1007/s10552-026-02236-y","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s10552-026-02236-y","pdf_url":null,"source":{"id":"https://openalex.org/S150168663","display_name":"Cancer Causes & Control","issn_l":"0957-5243","issn":["0957-5243","1573-7225"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Causes &amp; Control","raw_type":"journal-article"},{"id":"pmid:42640385","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42640385","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer causes & control : CCC","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0},{"display_name":"Reduced inequalities","id":"https://metadata.un.org/sdg/10","score":1.0}],"study_designs":[{"display_name":"Systematic Review","id":"https://openalex.org/study-designs/systematic-review"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":26,"referenced_works":["https://openalex.org/W2113740930","https://openalex.org/W2148685634","https://openalex.org/W2621271973","https://openalex.org/W2945890277","https://openalex.org/W2953287793","https://openalex.org/W2959687156","https://openalex.org/W3027715120","https://openalex.org/W3069915980","https://openalex.org/W3081315565","https://openalex.org/W3109589872","https://openalex.org/W3116163132","https://openalex.org/W3134914296","https://openalex.org/W3136171303","https://openalex.org/W3160798986","https://openalex.org/W3164115667","https://openalex.org/W3185777435","https://openalex.org/W3196536071","https://openalex.org/W4210842838","https://openalex.org/W4210895721","https://openalex.org/W4223505754","https://openalex.org/W4293435090","https://openalex.org/W4304084160","https://openalex.org/W4313621247","https://openalex.org/W4380730083","https://openalex.org/W4394933928","https://openalex.org/W4396762261"],"related_works":["https://openalex.org/W4399120993","https://openalex.org/W4411287793","https://openalex.org/W3194731446","https://openalex.org/W4210895721","https://openalex.org/W7171311673","https://openalex.org/W4410813457","https://openalex.org/W4394933928","https://openalex.org/W4376104438","https://openalex.org/W4414862353","https://openalex.org/W4411237031"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7204154339","counts_by_year":[],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2026-08-26T00:00:00"}
